SDC1 and Miyoshi myopathy: Interestingly, an analysis of residual MM cells in mice established that DTP3 achieved a virtually complete elimination of any viable CD138+ cells when administered once every day or once every other day, whereas DTP3 administration once every 3 days was significantly less effective in killing MM cells (Fig. 5C).